ArticleScientific reports2016

The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs.

Eliana Rulli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.